123 related articles for article (PubMed ID: 36271844)
1. Single-cell and bulk ICP-MS investigation of accumulation patterns of Pt-based metallodrugs in cisplatin-sensitive and -resistant cell models.
Lim SY; Low ZE; Tan RPW; Lim ZC; Ang WH; Kubota T; Yamanaka M; Pang S; Simsek E; Li SFY
Metallomics; 2022 Dec; 14(12):. PubMed ID: 36271844
[TBL] [Abstract][Full Text] [Related]
2. Quantitative evaluation of cellular uptake, DNA incorporation and adduct formation in cisplatin sensitive and resistant cell lines: Comparison of different Pt-containing drugs.
Corte-Rodríguez M; Espina M; Sierra LM; Blanco E; Ames T; Montes-Bayón M; Sanz-Medel A
Biochem Pharmacol; 2015 Nov; 98(1):69-77. PubMed ID: 26352094
[TBL] [Abstract][Full Text] [Related]
3. Quantitative Evaluation of Cisplatin Uptake in Sensitive and Resistant Individual Cells by Single-Cell ICP-MS (SC-ICP-MS).
Corte Rodríguez M; Álvarez-Fernández García R; Blanco E; Bettmer J; Montes-Bayón M
Anal Chem; 2017 Nov; 89(21):11491-11497. PubMed ID: 29023104
[TBL] [Abstract][Full Text] [Related]
4. Uptake of antitumor platinum(II)-complexes by cancer cells, assayed by inductively coupled plasma mass spectrometry (ICP-MS).
Ghezzi A; Aceto M; Cassino C; Gabano E; Osella D
J Inorg Biochem; 2004 Jan; 98(1):73-8. PubMed ID: 14659635
[TBL] [Abstract][Full Text] [Related]
5. Single-event tandem ICP-mass spectrometry for the quantification of chemotherapeutic drug-derived Pt and endogenous elements in individual human cells.
Liu T; Bolea-Fernandez E; Mangodt C; De Wever O; Vanhaecke F
Anal Chim Acta; 2021 Sep; 1177():338797. PubMed ID: 34482885
[TBL] [Abstract][Full Text] [Related]
6. Printing metal-spiked inks for LA-ICP-MS bioimaging internal standardization: comparison of the different nephrotoxic behavior of cisplatin, carboplatin, and oxaliplatin.
Moraleja I; Esteban-Fernández D; Lázaro A; Humanes B; Neumann B; Tejedor A; Luz Mena M; Jakubowski N; Gómez-Gómez MM
Anal Bioanal Chem; 2016 Mar; 408(9):2309-18. PubMed ID: 26825342
[TBL] [Abstract][Full Text] [Related]
7. In vitro studies on the mechanisms of oxaliplatin resistance.
Hector S; Bolanowska-Higdon W; Zdanowicz J; Hitt S; Pendyala L
Cancer Chemother Pharmacol; 2001 Nov; 48(5):398-406. PubMed ID: 11761458
[TBL] [Abstract][Full Text] [Related]
8. A novel method for speciation of Pt in human serum incubated with cisplatin, oxaliplatin and carboplatin by conjoint liquid chromatography on monolithic disks with UV and ICP-MS detection.
Martinčič A; Cemazar M; Sersa G; Kovač V; Milačič R; Ščančar J
Talanta; 2013 Nov; 116():141-8. PubMed ID: 24148385
[TBL] [Abstract][Full Text] [Related]
9. Impaired cisplatin influx in an A2780 mutant cell line: evidence for a putative, cis-configuration-specific, platinum influx transporter.
Helleman J; Burger H; Hamelers IH; Boersma AW; de Kroon AI; Stoter G; Nooter K
Cancer Biol Ther; 2006 Aug; 5(8):943-9. PubMed ID: 16775422
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells.
Samimi G; Safaei R; Katano K; Holzer AK; Rochdi M; Tomioka M; Goodman M; Howell SB
Clin Cancer Res; 2004 Jul; 10(14):4661-9. PubMed ID: 15269138
[TBL] [Abstract][Full Text] [Related]
11. Ultrasmall iron oxide nanoparticles cisplatin (IV) prodrug nanoconjugate: ICP-MS based strategies to evaluate the formation and drug delivery capabilities in single cells.
Turiel-Fernández D; Gutiérrez-Romero L; Corte-Rodriguez M; Bettmer J; Montes-Bayón M
Anal Chim Acta; 2021 May; 1159():338356. PubMed ID: 33867043
[TBL] [Abstract][Full Text] [Related]
12. Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin.
Samimi G; Kishimoto S; Manorek G; Breaux JK; Howell SB
Cancer Chemother Pharmacol; 2007 Feb; 59(3):301-12. PubMed ID: 16770583
[TBL] [Abstract][Full Text] [Related]
13. Joint forces of mass spectrometric techniques (ICP-MS and MALDI-TOF-MS) and fluorescence spectrometry in the study of platinum-based cytostatic drugs interactions with metallothionein MT2 and MT3.
Pavelicova K; Do T; Vejvodova M; Vaculovic T; Nowak K; Matczuk M; Wu S; Krężel A; Adam V; Vaculovicova M
Talanta; 2024 Jul; 274():125920. PubMed ID: 38574532
[TBL] [Abstract][Full Text] [Related]
14. Single-Cell ICP-MS in Combination with Fluorescence-Activated Cell Sorting for Investigating the Effects of Nanotransported Cisplatin(IV) Prodrugs.
Gutierrez-Romero L; Blanco-González E; Montes-Bayón M
Anal Chem; 2023 Aug; 95(32):11874-11878. PubMed ID: 37535006
[TBL] [Abstract][Full Text] [Related]
15. Combination effects of platinum drugs and N1, N11 diethylnorspermine on spermidine/spermine N1-acetyltransferase, polyamines and growth inhibition in A2780 human ovarian carcinoma cells and their oxaliplatin and cisplatin-resistant variants.
Tummala R; Diegelman P; Hector S; Kramer DL; Clark K; Zagst P; Fetterly G; Porter CW; Pendyala L
Cancer Chemother Pharmacol; 2011 Feb; 67(2):401-14. PubMed ID: 20443003
[TBL] [Abstract][Full Text] [Related]
16. Debio 0507 primarily forms diaminocyclohexane-Pt-d(GpG) and -d(ApG) DNA adducts in HCT116 cells.
King CL; Ramachandran S; Chaney SG; Collins L; Swenberg JA; DeKrafft KE; Lin W; Cicurel L; Barbier M
Cancer Chemother Pharmacol; 2012 Mar; 69(3):665-77. PubMed ID: 21968950
[TBL] [Abstract][Full Text] [Related]
17. Accumulation, fractionation, and analysis of platinum in toxicologically affected tissues after cisplatin, oxaliplatin, and carboplatin administration.
Esteban-Fernández D; Verdaguer JM; Ramírez-Camacho R; Palacios MA; Gómez-Gómez MM
J Anal Toxicol; 2008 Mar; 32(2):140-6. PubMed ID: 18334097
[TBL] [Abstract][Full Text] [Related]
18. Increased levels and defective glycosylation of MRPs in ovarian carcinoma cells resistant to oxaliplatin.
Beretta GL; Benedetti V; Cossa G; Assaraf YG; Bram E; Gatti L; Corna E; Carenini N; Colangelo D; Howell SB; Zunino F; Perego P
Biochem Pharmacol; 2010 Apr; 79(8):1108-17. PubMed ID: 20005867
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin enhanced the antitumor efficacy of oxaliplatin in cisplatin-resistant ovarian cancer cells A2780cis both in vitro and in vivo.
Liu J; Zhang L; Zhang X; Xing X
J Chemother; 2015; 27(6):358-64. PubMed ID: 25976336
[TBL] [Abstract][Full Text] [Related]
20. Complementarity of MALDI and LA ICP mass spectrometry for platinum anticancer imaging in human tumor.
Bianga J; Bouslimani A; Bec N; Quenet F; Mounicou S; Szpunar J; Bouyssiere B; Lobinski R; Larroque C
Metallomics; 2014 Aug; 6(8):1382-6. PubMed ID: 24984817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
